February 13, 2026
Can You Get Ruxolitinib for Vitiligo in South Africa?
Ruxolitinib is a Janus kinase (JAK) 1/JAK2 inhibitor, a type of targeted immune therapy that…
August 18, 2023
Vitiligo Treatment Updates
Dr. John Harris discusses the current and future landscape for vitiligo treatment. Vitiligo Treatment Updates…
August 18, 2023
Anxiety And Depression In Pediatric Patients With Vitiligo And Alopecia Areata And Their Parents: A Cross-Sectional Controlled Study
1 | INTRODUCTION Anxiety and depressive disorders are the most common psychopathologies in children and adolescents.1 Alopecia…
August 18, 2023
JAK inhibitors offer hope for vitiligo patients
John Jesitus Conference | American Academy of Dermatology With several Janus kinase (JAK) inhibitors undergoing…
